In this special episode of Trending Health, Mindy McGrath and Karen Baldry explore how recent changes across the U.S. federal health agencies and policies from the new administration are impacting the life sciences and biotech industry compounding with other pressures like the IRA, tariffs, and budget constraints. From launch delays at the FDA to supply chain strain and evolving patient access challenges, Mindy and Karen provide strategic considerations for commercial leaders as they navigate these shifts and uncertainties.To learn more about how we can help your team with scenario planning and navigating these strategic decisions, reach out to Karen.Baldry@vynamic.com (mailto:Karen.Baldry@vynamic.com). Check out our recent insights for more information: U.S. Federal Health Agency Layoffs Pose Strategic Risk and Disruption to Life Sciences (%5C) & The Case for Strategic Transformation: An Executive Conversation with Vynamic’s Leaders (%5C) Podcast Tags: healthcare, life sciences, public health, life sciences trends, healthcare strategy, health innovation Panel – Mindy McGrath, Karen Baldry Research & Production – Mindy McGrath, Karen Baldry, Everly Petruzzelli Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com (%5C).